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The classical tango is a dance characterized by a 2/4 or 4/4 rhythm in which the part-
ners dance in a coordinated way, allowing dynamic contact. There is a surprising similarity
between the tango and how KCNE β-subunits “dance” to the fast rhythm of the cell with
their partners from the Kv channel family. The five KCNE β-subunits interact with several
members of the Kv channels, thereby modifying channel gating via the interaction of their
single transmembrane-spanning segment, the extracellular amino terminus, and/or the
intracellular carboxy terminus with the Kv α-subunit. Best studied is the molecular basis
of interactions between KCNE1 and Kv7.1, which, together, supposedly form the native
cardiac IKs channel. Here we review the current knowledge about functional and molecu-
lar interactions of KCNE1 with Kv7.1 and try to summarize and interpret the tango of the
KCNEs.
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INTRODUCTION
Voltage-gated potassium channels (Kv) are ubiquitously expressed
in human tissues. They enable the rapid, selective movement of
potassium ions through cellular membranes, thereby regulating
physiological processes such as transmembrane ion passage and
hormone secretion, vesicle cycling, and cell excitability. Kv chan-
nels display a huge diversity due to the large number of different α-
subunits, alternative splicing, post-transcriptional modifications,
and their ability to form heteromeric channels with other pore-
forming α-subunits. To complicate the situation even more, the
number of functionally different Kv channels in native tissues is
further increased by interaction with regulatory β-subunits. These
accessory subunits modify subcellular localization as well as bio-
physical properties of Kv channels such as gating kinetics, ion
selectivity, and pharmacology. Among the best studied modu-
lations of Kv channels by regulatory β-subunits is the effect of
KCNE1 on Kv7.1.
Kv7.1-EXPRESSION AND PHYSIOLOGICAL FUNCTION
The KCNQ1 gene was first identified by Wang et al. (1996b) in
a linkage study of patients with long QT syndrome (LQTS1).
Its gene product, Kv7.1 (also termed KvLQT1 or KCNQ1), is a
voltage-gated potassium channelα-subunit, and its expression was
detected in several mammalian tissues, including heart, epithelia,
and smooth muscle (Figure 1; Table A1 in Appendix). Kv7.1 can
assemble with different members of the KCNE family of regulatory
β-subunits to fulfill a variety of physiological functions.
In the heart, Kv7.1 is involved in the termination of the cardiac
action potential. The repolarizing potassium current, I K, consists
of two major components, the rapid delayed rectifier potassium
current I Kr and the slow delayed rectifier potassium current I Ks
(Sanguinetti and Jurkiewicz, 1990). Kv7.1 coassembles with the
KCNE1 β-subunit to form the channel complex that mediates I Ks
(Barhanin et al., 1996; Sanguinetti et al., 1996). Although KCNE1
is the major accessory subunit assembling with Kv7.1 in the heart,
other subunits of the KCNE family might be present (Bendah-
hou et al., 2005), serving as additional regulators of I Ks (Wu
et al., 2006). The significance of Kv7.1 and its accessory β-subunits
for maintaining normal rhythmicity is further emphasized by the
numerous KCNQ1 and KCNE mutations associated with cardiac
arrhythmias (http://www.fsm.it/cardmoc/). Most of these muta-
tions lead to loss of channel function causing LQTS, a disorder
predisposing affected individuals to torsade de pointes arrhythmia
and cardiac sudden death.
Besides its cardiac function, several lines of evidence suggest
an important role of Kv7.1 and its accessory β-subunit KCNE1 in
the hearing process. In patients suffering from Jervell and Lange-
Nielsen syndrome – the recessive form of inherited LQTS – cardiac
arrhythmia is accompanied by profound bilateral deafness. Muta-
tions in both KCNQ1 and KCNE1 genes have been reported to
cause this disorder (Jervell and Lange-Nielsen, 1957; Neyroud
et al., 1997; Schulze-Bahr et al., 1997). In addition, targeted dis-
ruption of the KCNQ1 gene in mice leads to deafness caused by
morphological abnormalities of the inner ear (Lee et al., 2000;
Casimiro et al., 2001). Expression of Kv7.1 and KCNE1 has been
detected in the marginal cells of the stria vascularis of the cochlea
and the vestibular dark cells (Neyroud et al., 1997; Nicolas et al.,
2001; Knipper et al., 2006; Hur et al., 2007). Both cell types are
involved in the generation of the potassium-rich endolymph, and
Kv7.1/KCNE1 channels have been suggested to be key mediators
of this K+ secretion (Marcus and Shen, 1994; Shen et al., 1995;
Wangemann, 1995; Wangemann et al., 1995; Sunose et al., 1997).
In addition to the inner ear epithelium, Kv7.1 has been detected
in a variety of other epithelial cell types, where it participates
in secretory transduction. In the kidney, Kv7.1/KCNE1 chan-
nels seem to be located in the proximal tubule of the nephron
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FIGURE 1 | Distribution of Kv7.1. Kv7.1 is expressed in several tissues
throughout the human body, including heart, lung, inner ear, kidney, and the
gastrointestinal tract.
(Sugimoto et al., 1990; Vallon et al., 2001), conducting a K+ cur-
rent to counterbalance membrane depolarization induced by elec-
trogenic Na+-coupled transport of glucose or amino acids (Val-
lon et al., 2001, 2005). The relevance of Kv7.1/KCNE1 channels
for renal function is further underlined by the observation that
KCNE1 knockout mice suffer from hypokalemia, urinary and fecal
salt wasting, and volume depletion (Arrighi et al., 2001; Warth and
Barhanin, 2002). Kv7.1 expression has also been detected in the
small intestine and the colon (Schroeder et al., 2000; Dedek and
Waldegger, 2001; Demolombe et al., 2001; Kunzelmann et al., 2001;
Horikawa et al., 2005). In colonic crypt cells Kv7.1 is believed to
assemble with another accessory β-subunit, KCNE3, and to medi-
ate a K+ conductance that provides the driving force for chloride
secretion (Schroeder et al., 2000; Kunzelmann et al., 2001). Two
further examples of Kv7.1 expression and function in chloride-
secreting tissues are pancreatic acinar cells and airway epithelium
(Kim and Greger, 1999; Kottgen et al., 1999; Mall et al., 2000;
Demolombe et al., 2001; Grahammer et al., 2001b; Lee et al., 2004).
In parietal cells of the stomach Kv7.1 coassembles with KCNE2
and participates in gastric acid secretion (Dedek and Waldegger,
2001; Demolombe et al., 2001; Grahammer et al., 2001a; Heitz-
mann et al., 2004). In KCNQ1 knockout mice gastric hyperplasia
and profound hypochlorhydria have been observed, indicating the
importance of Kv7.1 in normal stomach development and func-
tion (Lee et al., 2000). Kv7.1 expression has also been detected
in the human thyroid gland, and it has been shown that mice
lacking functional Kv7.1 develop hypothyroidism (Frohlich et al.,
2011). Recently, Kv7.1 channels have been shown to relax systemic
and pulmonary arteries upon pharmacological activation (Chadha
et al., 2012).
REGULATION OF Kv7.1 BY ACCESSORY β-SUBUNITS OF THE
KCNE GENE FAMILY
All five members of the KCNE family of regulatory β-subunits
can functionally coassemble with Kv7.1 to subunit-specifically
change its current characteristics (for an excellent review about
KCNEs, see McCrossan and Abbott, 2004). The founding mem-
ber KCNE1 (previously termed MinK or I sK) was identified in
1988 (Takumi et al., 1988). As its expression in Xenopus oocytes
produced slowly activating potassium currents resembling the car-
diac I Ks, KCNE1 was originally believed to be the ion channel
α-subunit forming the I Ks channel. However, it is now well estab-
lished that KCNE1 cannot form functional K+ channels alone,
but can serve as a regulatory β-subunit for several voltage-gated
cation channels, including Kv7.1 (Barhanin et al.,1996; Sanguinetti
et al., 1996). The I Ks-like potassium currents observed in oocytes
upon heterologous expression of KCNE1 were actually caused
by coassembly with endogenous Kv7.1. So far, four other mem-
bers of the KCNE family, KCNE2-KCNE5 (also termed MiRP1-4)
have been identified (Abbott et al., 1999; Piccini et al., 1999), and
their influence on Kv7.1 channels has been studied extensively
in heterologous expression systems. Kv7.1 expressed alone forms
a classical delayed rectifier potassium-selective channel with fast
activation, delayed partial inactivation, and relatively slow deacti-
vation (Pusch et al., 1998; Tristani-Firouzi and Sanguinetti, 1998).
The presence of KCNE1 drastically modifies Kv7.1 activity by
increasing unitary conductance as well as macroscopic currents,
slowing activation, right-shifting voltage dependence of activa-
tion, suppressing currents at low activating voltages, suppress-
ing partial inactivation, increasing Q10-value, and modulating
pharmacology (Figures 2A–C; Barhanin et al., 1996; Sanguinetti
et al., 1996; Pusch, 1998; Pusch et al., 1998; Sesti and Gold-
stein, 1998; Tristani-Firouzi and Sanguinetti, 1998; Lerche et al.,
2000; Seebohm et al., 2001a,b,c, 2003a,b,c, 2005; Morokuma et al.,
2008). Coassembly of Kv7.1 and KCNE2 gives rise to currents
with decreased amplitude, instantaneous activation, rapid par-
tial deactivation, and a linear current-voltage relationship (Tinel
et al., 2000). KCNE3 also converts Kv7.1 to a channel with nearly
instantaneous activation and a linear current-voltage relationship
(Schroeder et al., 2000; Seebohm et al., 2003c), but in contrast
to Kv7.1/KCNE2, complexes containing KCNE3 show some time
dependency of gating at positive potentials and increased current
densities (Schroeder et al., 2000; Melman et al., 2001; Mazhari
et al., 2002). KCNE4 completely suppresses Kv7.1 currents at phys-
iologically relevant membrane potentials (Grunnet et al., 2002)
and KCNE5 shifts the voltage dependence of Kv7.1 activation
to more positive potentials toward an activation threshold of
about +40 mV (Figure 2D; Angelo et al., 2002; Seebohm et al.,
2003c).
GATING OF Kv7.1 AND ITS MODULATION BY KCNE1
The biophysical properties of voltage-gated Kv7.1 channels change
dramatically when they coassemble with KCNEs. Homotetrameric
Kv7.1 channels activate with relatively fast kinetics with τactivation
by about 80−100 ms at 60 mV (Figure 2; Pusch et al., 1998;
Tristani-Firouzi and Sanguinetti, 1998). The channels undergo
partial inactivation, with about 60% of the channels being inacti-
vated at 60 mV in steady-state (Figure 2). The kinetic behavior of
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FIGURE 2 | Characteristics of Kv7.1/KCNE-mediated currents. (A)
Representative current traces of Kv7.1 homomers and Kv7.1/KCNE1
heteromers. Channels were expressed in Xenopus oocytes, and currents
were elicited with 7 s pulses to potentials of −100 to +60 mV, applied in
20 mV increments from a holding potential of −80 mV. Tail currents were
recorded at −120 mV. (B) Current-voltage relationships. At voltages
between −60 and −40 mV KCNE1 suppresses currents, whereas it
stimulates them at voltages above 0 mV. (C) Voltage dependence of
channel activation determined by tail current analysis. Activation curves
were fitted to a Boltzmann function. Note: Kv7.1/KCNE1 channels are not
fully activated at +60 mV. (D) Effects of different KCNE subunits on Kv7.1
currents. “+” and “++” indicate increased and strongly increased effects,
while “−” and “−−” indicate decreased and strongly decreased effects,
respectively. *Effect shown in the calmodulin binding-deficient
KCNE4L69–L72 mutant (Ciampa et al., 2011). The Rb+/K+ conductance tightly
correlates with the partial inactivation, and KCNE5 slightly increases it,
whereas KCNE1/3 decreases it compared to Kv7.1 (Seebohm et al.,
2003c).
Kv7.1 can be approximated by a linear gating scheme of the form
(Pusch et al., 1998; Tristani-Firouzi and Sanguinetti, 1998):
model 1:
In this model C1 C2, C2 C3, and O1 O2 are the
voltage-dependent gating steps. Recently, an alternative circular
gating scheme was proposed by Ma et al. (2011).
model 2:
This novel gating scheme accounts for an open fraction that
is determined by allosteric coupling of residues in the S4–
S5 linker/pore domain (PD). C1 C2 and O1 O2 are the
voltage-dependent gating steps.
Kv7.1/KCNE1 heteromeric channels activate far more slowly
and at more positive potentials than homomeric Kv7.1 channels,
do not partially inactivate, and have an increased single-channel
conductance compared to homomeric Kv7.1 recorded in standard
extracellular solutions (Barhanin et al., 1996; Sanguinetti et al.,
1996; Pusch, 1998; Pusch et al., 1998; Tristani-Firouzi and San-
guinetti, 1998). It is believed that Kv7.1/KCNE1 channel currents
resemble the cardiac repolarizing, slowly activating potassium
current I Ks and that LQTS1/5 mutations might directly or alloster-
ically modify interactions of Kv7.1 and the β-subunit KCNE1 (e.g.,
Schmitt et al., 2000; Seebohm et al., 2001c; Osteen et al., 2010;
Wang et al., 2011b). Cui et al. (1994) proposed two linear-branched
gating schemes for Kv7.1/KCNE1 heteromers, which depend on
varying KCNE1 amounts coexpressed with Kv7.1 and imply inter-
actions among individual channel proteins during activation. Yet
Tzounopoulos et al. reported on a crossover gating phenomenon
after prepulsing to different voltages that cannot be explained by a
classical Cole–Moore shift in a linear gating model of Kv7.1/KCNE1
channels and presented results that argue for a circular gating
model similar to model 2 (Cole and Moore, 1960; Tzounopou-
los et al., 1998). However, a branched model can account for
this crossover gating phenomenon after prepulsing to different
voltages as well (Strutz-Seebohm et al., 2011):
model 3:
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Further gating schemes have been proposed to describe
Kv7.1/KCNE1 gating (Silva and Rudy, 2005, 2010; Osteen et al.,
2010; Ghosh et al., 2011). In summary, the gating behaviors
of Kv7.1 and Kv7.1/KCNE1 are relatively complex, and simple,
linear gating models reach too short to approximate a realistic
mathematical description.
STOICHIOMETRY OF THE Kv7.1/KCNE1 COMPLEX
After the discovery that the channel complex mediating the car-
diac I Ks is composed of Kv7.1 α-subunits and KCNE1 β-subunits
(Barhanin et al., 1996; Sanguinetti et al., 1996), detailed investiga-
tions on the nature of this association started. Like all members of
the Kv channel family, Kv7.1 α-subunits assemble into tetramers
to form functional channels. Each α-subunit consists of six trans-
membrane segments, S1–S6, flanked by intracellular amino- and
carboxy-terminal domains. The central pore domain (PD) of the
channel, which contains the ion conduction pathway and the
activation gate, is formed by segments S5 and S6 and the pore
loop between them. The pore loop carries the K+ channel sig-
nature sequence TTIGYGD allowing rapid ion conduction and
potassium selectivity. The PD is surrounded and controlled by
four voltage-sensing domains (VSDs) formed by segments S1–S4
from each subunit (Figures 3A,B). S4 contains several positively
charged amino acids and is a key element of voltage sensing. Fur-
ther charged residues in S1–S3 may contribute additional charge to
allow for voltage sensing. Tetrameric assembly of Kv7.1 α-subunits
is mediated via their C-terminal domains (Schmitt et al., 2000;
Schwake et al., 2003). Although Kv7.1 homotetramers are func-
tional, the presence of the accessory β-subunit KCNE1 is needed
to produce currents with characteristics of native I Ks (Figure 2A).
KCNE1 is a small, integral membrane protein with a single
transmembrane-spanning segment flanked by an extracellular N-
terminal and an intracellular C-terminal domain (Figure 3A).
The number of KCNE1 β-subunits recruited by tetrameric Kv7.1
channels has been a matter of extensive debate (Figure 3B). Pre-
vious studies have either suggested a fixed stoichiometry of four
Kv7.1 subunits and two KCNE1 subunits (Wang and Goldstein,
1995; Chen et al., 2003a; Kang et al., 2008; Morin and Kobertz,
2008) or a variable stoichiometry with up to four KCNE1 subunits
assembling with a Kv7.1 tetramer (Cui et al., 1994; Wang et al.,
1998, 2011a; Morokuma et al., 2008; Nakajo et al., 2010; Zheng
et al., 2010; Strutz-Seebohm et al., 2011). A summary of the data
obtained during the last two decades is provided in Table 1. The
results reported leave the possibility open that KCNE1 subunits
coassemble with Kv7.1 in different modes allowing up to four
KCNE1 subunits to approach the Kv7.1 tetramer but permitting
only formation of 4 Kv7.1 : 2 KCNE1 assemblies in specific regions
of the heteromeric channels. Prerequisites for such an interac-
tion would be variable and dynamic interactions. Indeed, several
studies suggest interactions of Kv7.1 with KCNE1 at different pro-
tein regions in the various channel states (summarized in Table 2).
However, further studies are required to support such a hypothesis.
STRUCTURAL BASIS OF Kv7.1/KCNE1 INTERACTION
The structural basis of the Kv7.1/KCNE1 interaction has been
studied extensively over the last 20 years. Experimental data
obtained from deletion analysis, chimeric approaches, and
site-directed mutagenesis identified regions in both Kv7.1 and
KCNE1 that might be crucial for association and modulation
(summarized in Table 2). Based on these data it has been suggested
that the transmembrane segment and the C-terminal domain
of KCNE1 mediate its ability to modulate Kv7.1 (Takumi et al.,
1991; Tapper and George, 2000). Molecular key elements of
KCNE1 function seem to be three glycines, several bulky, aro-
matic phenylalanines, and the threonine 58 located at the center
of the KCNE1 transmembrane segment (Melman et al., 2001, 2002;
Strutz-Seebohm et al., 2011). A comparison with other KCNE sub-
units underscores the importance of the transmembrane segment
for KCNE function: interactions of Kv7.1 with KCNE1 and Kv7.1
with KCNE3 show similar chemical modification rates within the
transmembrane region (Rocheleau and Kobertz, 2008), and the
KCNE4 transmembrane segment modulates voltage dependence
of Kv7.1 activation (Ciampa et al., 2011). A recent study indicates
that different KCNE proteins contact different regions in Kv7.1 all
located within the transmembrane segments (Nakajo et al., 2011).
In segment S6 of Kv7.1, a three amino acid motif (S338, F339,
FIGURE 3 |Topology and stoichiometry of Kv7.1/KCNE1 channels.
(A) Kv7.1 α-subunits are made of six membrane-spanning segments
S1–S6 and intracellular N- and C-terminal domains. The segments S1–S4
form the voltage-sensing domain (VSD), while the pore domain (PD)
consists of segments S5 and S6. KCNE1 β-subunits contain a single
transmembrane segment flanked by an extracellular N-terminus and a
cytosolic C-terminus. (B) Four Kv7.1 α-subunits assemble to form a
functional channel. The number of KCNE1 β-subunits associating with
Kv7.1 tetramers is still a matter of extensive debate (Strutz-Seebohm
et al., 2011).
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Table 1 | Stoichiometry of Kv7.1/KCNE1 channels.
Experimental evidence leading to conclusion of fixed stoichiometry (4:2) Reference
Suppression of current induced by coexpression of wildtype and mutant KCNE1 indicates 4:2 stoichiometry Wang and Goldstein (1995)
Kv7.1/Kv7.1/KCNE1 fusion proteins and naturally assembled Kv7.1/KCNE1 channels show similar characteristics of CTX
inhibition; quantification of Kv7.1 and KCNE1 subunits using 3H-CTX and an antibody indicates a 4:2 stoichiometry
Chen et al. (2003a)
Chemical subunit counting experiments indicate that association of two KCNE1 subunits with the Kv7.1 tetramer is
sufficient to induce KCNE1-typical modulation of channel properties
Morin and Kobertz (2008)
Computational model of Kv7.1/KCNE1 channels indicates that binding of more than two KCNE1 subunits to the Kv7.1
tetramer might be sterically hindered
Kang et al. (2008)
Experimental evidence leading to conclusion of variable stoichiometry Reference
Current amplitude, activation kinetics, and voltage dependence of Kv7.1/KCNE1 channels vary with the amount of KCNE1 Cui et al. (1994)
Both Kv7.1/KCNE1 fusion proteins and Kv7.1–Kv7.1 with additional KCNE1 produce currents with activation kinetics and
voltage dependence similar to naturally assembled Kv7.1/KCNE1 channels
Wang et al. (1998)
Voltage dependence of activation of Kv7.1/KCNE1 channels varies with the amount of KCNE1 Morokuma et al. (2008)
Single-molecule fluorescent bleaching studies indicate that up to four KCNE1 subunits associate with the Kv7.1 tetramer
depending on the relative densities of the two subunits
Nakajo et al. (2010)
Effects of free KCNE1 C-terminals on voltage dependence of activation of Kv7.1 and Kv7.1/KCNE1 channels are complex,
indicating multiple stoichiometries or saturation of possible binding sites
Zheng et al. (2010)
Overexpression of KCNE1 markedly changed activation kinetics and voltage dependence of native IKs, indicating
assembly of additional KCNE1 subunits with endogenous channels
Wang et al. (2011a)
Modeling of transmembrane domain suggests that variable stoichiometry seems possible in this region Strutz-Seebohm et al. (2011)
F340) has been identified that might constitute a site of specific
interaction with KCNE1, especially with its residue T58 (Melman
et al., 2004; Panaghie et al., 2006; Strutz-Seebohm et al., 2011). Fur-
ther residues in the pore region of Kv7.1 (F270, G272, and L273 in
S5, V307, V310, and T311 in the lower pore helix, and V324 and
V334 in the upper S6) are crucial for an accurate modulation by
KCNE1 (Seebohm et al., 2001c, 2003c; Nakajo et al., 2011).
Based on experimental evidence, localizations of KCNE1 in
the channel complex have been suggested. A series of observa-
tions obtained from cysteine scanning mutagenesis combined with
chemical modifications (Cd2+ coordination, MTS reagent bind-
ing, and spontaneous disulfide formation) indicate that KCNE1
lies in close proximity to both the PD and the VSD of the Kv7.1
tetramer (summarized in Table 2). First interpretations suggested
that KCNE1 lines the conduction pathway (Wang et al., 1996a; Tai
and Goldstein, 1998). However, subsequent studies indicate that
the KCNE1 transmembrane segment is located outside the PD and
interacts with the outer S5 and S6 segments of Kv7.1 (Lerche et al.,
2000; Kurokawa et al., 2001; Tapper and George, 2001; Chung et al.,
2009; Strutz-Seebohm et al., 2011). Its extracellular flank seems to
face the extracellular ends of segments S1 and S6 of Kv7.1, with
the residues interacting with segment S1 varying dependent on
the specific channel state (Xu et al., 2008; Chung et al., 2009).
In addition to segment S1 of the VSD and S5/S6 of the PD, the
transmembrane domain of KCNE1 gets in close contact with the
primary cationic voltage sensor S4 (Nakajo and Kubo, 2007; Sham-
gar et al., 2008; Silva et al., 2009; Strutz-Seebohm et al., 2011). A
possible interaction of KCNE1 with the VSD of Kv7.1 is further
underscored by the fact that the abnormal phenotypes of several
disease-causing mutations in S1, S4, or the S4–S5 linker of Kv7.1
in vitro only manifest in the presence of KCNE1 (summarized in
Table 2; Franqueza et al., 1999; Chouabe et al., 2000; Chen et al.,
2003c; Chan et al., 2012). The cytoplasmic portion directly follow-
ing the transmembrane segment of KCNE1 seems to interact with
the gating machinery of Kv7.1 (Lvov et al., 2010). A hallmark of
all Kv7 channels is their sensitivity to muscarinic signaling, which
gave them the name M-channels. The Kv7.1 membrane-proximal
region may link membrane lipid metabolism of phosphoinosi-
tide PI(4,5)P2 to the gating machinery to allow for integration
of muscarinic signaling into gating alterations in Kv7.1 (Ikeda
and Kammermeier, 2002; Loussouarn et al., 2003). The lower
S6 is expected to be in close proximity to allow for electrostatic
interaction with the PI(4,5)P2 head groups, and PI(4,5)P2 bind-
ing sites have been reported to be positioned close to the lower
S6-helices bundle in the PD of Kv7.1 (Loussouarn et al., 2003;
Thomas et al., 2011). However, it may be mentioned that fur-
ther PI(4,5)P2 binding sites may exist in the TM domain. KCNE1
residues R67SKKLEH73 in the vicinity of the inner membrane
leaflet increase the PI(4,5)P2 sensitivity of Kv7.1 by a factor of 100,
possibly by electrostatic interaction with PI(4,5)P2 head groups
and/or Kv7.1 residues interacting with PI(4,5)P2 (Li et al., 2011).
Thus, PI(4,5)P2 may function as a molecular coupler of Kv7.1 and
KCNE1 to modulate gating in complex ways.
Recent structural modeling approaches generated 3D models of
the transmembrane region of Kv7.1/KCNE1 that are in large agree-
ment with the various experimental data. Specifically, homology
modeling of the Kv7.1 S1–S6 region and Rosetta-based docking
of the KCNE1 transmembrane domain produced an open and a
closed state model of the heteromeric channel complex (Smith
et al., 2007; Kang et al., 2008). Very recently, homology model-
ing of Kv7.1 with manual docking of the KCNE1 transmembrane
domain was used to generate a pre-open closed state model of
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Table 2 | Structural basis of Kv7.1/KCNE1 interaction.
Approach Conclusion Reference
Deletion analysis, chimeric
approach, and/or site-directed
mutagenesis
TM segment and cytoplasmic portion immediately following TM segment of KCNE1
mediate KCNE1 function
Takumi et al. (1991)
TM segment and C-terminal domain of KCNE1 mediate KCNE1 function Tapper and George (2000)
Residues 57–59 of KCNE1 are important for KCNE1 function (“activation triplet”) Melman et al. (2001)
Residue L273 of Kv7.1 is important for normal modulation by KCNE1 Seebohm et al. (2001c)
Residue T58 is a key element of KCNE1 function Melman et al. (2002)
Requirements to interact with KCNE1 are located in regions C-terminal to S5;
Residues S338, F339, and F340 in S6 are important for normal modulation by KCNE1
Melman et al. (2004)
Residues S338, F339, and F340 in S6 are possible interaction sites of KCNE1 Panaghie et al. (2006)
KCNE1 C-terminus is crucial for channel assembly, open state destabilization,
kinetics of deactivation
Chen et al. (2009)
Amino acids important for normal modulation by KCNE1 are located in S5 and S6
(G272, V324, V334) of Kv7.1
Nakajo et al. (2011)
Cysteine scanning mutagenesis
combined with chemical
modifications (Cd2+
coordination, MTS reagent
binding, and spontaneous
disulfide formation)
TM segment of KCNE1 lines the conduction pathway Wang et al. (1996a)
TM segment of KCNE1 lines the conduction pathway Tai and Goldstein (1998)
KCNE1 is located outside the conduction pathway Kurokawa et al. (2001)
KCNE1 is located outside the conduction pathway but in very close proximity to S6
of Kv7.1
Tapper and George (2001)
E44 in KCNE1 is close to A226 in S4 of Kv7.1 in the open state; KCNE1 is close to or
possibly interacts with the VSD
Nakajo and Kubo (2007)
KCNE1 makes state-dependent contact with S1 of Kv7.1; KCNE1 is in close
proximity to the VSD
Xu et al. (2008)
KCNE1 is located close to S1 and S4 of two adjacent VSDs Shamgar et al. (2008)
C-terminal region directly following the KCNE1 TM segment interacts with activation
gate of Kv7.1
Lvov et al. (2010)
Proof of direct physical
interaction or close proximity
(e.g., co-immunoprecipitation,
FRET)
C-terminus of KCNE1 directly interacts with the pore region of Kv7.1 Romey et al. (1997)
C-termini of Kv7.1 and KCNE1 move close to each other during channel activation;
distal C-terminus of KCNE1 interacts with dimeric coiled coil helix C of Kv7.1
Haitin et al. (2009)
Physical interaction between C-termini of Kv7.1 and KCNE1; portion of A-helix and its
linker to S6 bind KCNE1
Zheng et al. (2010)
Analysis of disease-causing
mutations
Functional interaction of KCNE1 with S4/S4–S5 linker of Kv7.1 Franqueza et al. (1999)
Functional interaction of KCNE1 with S4/S4–S5 linker of Kv7.1 Chouabe et al. (2000)
Functional interaction of KCNE1 with S1 of Kv7.1 Chan et al. (2012)
Computational model KCNE1 is located in a cleft between the pore domain and the VSD of Kv7.1 Kang et al. (2008)
KCNE1 binds to the outer face of the Kv7.1 channel pore, KCNE1 is located in a cleft
between pore domain and VSD of Kv7.1
Strutz-Seebohm et al. (2011)
the Kv7.1/KCNE1 channel (Strutz-Seebohm et al., 2011). All three
models are relatively stable in molecular dynamics simulations,
which suggests that they are close to native states.
The C-termini of Kv7.1 and KCNE1 are in close proximity
and physically interact, as indicated by FRET measurements and
co-immunoprecipitation, yet the structural basis of this interac-
tion is unknown (Haitin et al., 2009; Zheng et al., 2010). The
cytosolic domain of Kv7.1/KCNE1 channels represents a multi-
modular structure serving multiple functions. It contains several
amphipathic α-helices. Structural prediction algorithms place two
α-helices, A and B, to the proximal C-terminus of Kv7.1 (Haitin
and Attali, 2008). These α-helices may contain functionally rel-
evant calmodulin interaction motifs. The residues Kv7.1586–618
form α-helix D that contain a leucine-zipper and a coiled coil
fold (Kanki et al., 2004). This parallel, four-stranded coiled coil
allows for specific tetrameric assembly of Kv7.1 channel sub-
units (Schmitt et al., 2000; Schwake et al., 2003; Nakajo and
Kubo, 2008). Recently, Xu and Minor (2009) presented a high-
resolution X-ray crystal structure (1.7 Å resolution) of Kv7.1583–611
confirming the predictions of the coiled coil assembly speci-
ficity domain. Interestingly, helix D is supposedly two helical
turns longer in this crystal structure than helices D of the closely
related Kv7.2–5 channels, which allows for specific homomeric
assembly with other Kv7.1 subunits but not for heteromeric
assemblies with other family members (Haitin and Attali, 2008;
Xu and Minor, 2009). The S6 transmembrane segment and the
Frontiers in Pharmacology | Pharmacology of Ion Channels and Channelopathies August 2012 | Volume 3 | Article 142 | 6
Wrobel et al. Kv7.1/KCNE1 interaction
A-domain are linked by the region Kv7.1350–582, which accord-
ing to in silico prediction assumes an apo-chloroperoxidase fold
and can thus be modeled using the structural coordinates of
apo-chloroperoxidase (pdb: 1VNS; Macedo-Ribeiro et al., 1999).
However, these predictions appear somewhat preliminary, and
several assumptions have to be made to incorporate the mod-
eled region into the rest of the Kv7.1–3D model. Further, how
exactly the proposed helices A/B and linker region containing the
calmodulin binding site can be integrated into this fold is specu-
lative. The structural folds of the N-terminal region Kv7.11–115
and the most distal residues Kv7.1612–676 remain completely
unknown.
PI(4,5)P2 modulates function of Kv7.1/KCNE1 channels, and
functional PI(4,5)P2 interaction sites were reported not only for
the lower S6 segment but also for the C-terminus, where a clus-
ter of basic amino acids may form a PI(4,5)P2 interaction site
allowing for electrostatic interactions with the PI(4,5)P2 head
groups (Loussouarn et al., 2003; Zhang et al., 2003; Delmas and
Brown, 2005). This PI(4,5)P2 interaction site may functionally
and physically overlap with the calmodulin binding sites in the
inter helix A/B linker region (Hernandez et al., 2008). The Kv7.1–
calmodulin interaction can be modulated by coassembly with
KCNE4. This modulation is dependent on a juxtamembrane tetra-
leucine motif (L69–L72) in KCNE4. However, deletion of this
motif leaves the kinetic effects on Kv7.1 mediated by the KCNE4
transmembrane domain intact (Ciampa et al., 2011). Possibly,
PI(4,5)P2 and calmodulin “glue” these C-terminal regions to the
transmembrane proximal regions mentioned above and allow for
modulation of gating at the activation gate and the VSD. Clearly,
further evidence is needed to prove this hypothesis (Li et al.,
2011).
The C-termini of Kv7.1/KCNE1 channels physically interact
with several proteins like the AKAP yotiao, epidermal growth
factor receptor kinase, and NEDD4.2 (Marx et al., 2002; Kanki
et al., 2004; Kurokawa et al., 2004; Jespersen et al., 2007; Dong
et al., 2010). The protein kinase A phosphorylates Ser27 in the N-
terminus of Kv7.1 and modulates Kv7.1/KCNE1 function (Marx
et al., 2002). This modulation critically depends on the presence of
KCNE1 (Marx et al., 2002; Kurokawa et al., 2004). This observation
suggests that the Kv7.1 N-terminus contributes to Kv7.1/KCNE1
subunit interaction. The binding sites for these proteins have to
be located at the surface of the C-terminal structure to be acces-
sible for interaction. This information will be of help for further
structural modeling. A 3D model of the Kv7.1/KCNE1 channel
satisfying most of the aforementioned hypotheses is shown in
Figure 4.
TOWARD A DYNAMIC VIEW ON STRUCTURAL
REARRANGEMENTS DURING Kv7.1/KCNE1 GATING
In the last 14 years a wealth of potassium channel crystal structures
have been reported. Although central structural elements in Kv7.1
clearly differ from classical Shaker-type Kv channels, the available
crystal structures are well-suited templates to model the Kv7.1 S1–
S6 region in different states (Seebohm et al., 2006; Silva et al., 2009).
Direct interactions of the transmembrane segments of Kv7.1 with
KCNE1 have been proposed, but the specific amino acid interac-
tions remain controversial (summarized in Table 2). CD spectra
FIGURE 4 | Structural model of the Kv7.1 channel. The transmembrane
domain of the Kv7.1 channel bears the common Kv channel structure.
Homology models using the solved crystal structural constraints allow for
good model predictions (gray). For docking experiments the solved
NMR-structural data of the full-length KCNE1 in lipid environments can be
used (here only the transmembrane segment is shown in red; Tian et al.,
2007; Kang et al., 2008). The structure of the Kv7.1 tetrameric assembly
domain (A-domain) was solved and can be incorporated into a model (Xu
and Minor, 2009). The region linking the S6 and the A-domain shows amino
acid similarity to the structure 1VNS.pdb. No structures or even template
coordinates for the Kv7.1 N-terminus and the distal C-terminus are available
and thus homology modeling is currently problematic.
in a membrane-like environment and the NMR solution struc-
ture of KCNE1 transmembrane peptides show that this peptide
adopts an α-helical structure (Aggeli et al., 1998; Strutz-Seebohm
et al., 2011). Recently, two NMR structures of full-length KCNE1
confirmed that the transmembrane segment of KCNE1 folds an
α-helix (Tian et al., 2007; Kang et al., 2008). An open and a closed
state model of Kv7.1/KCNE1 channels were proposed based on
the NMR-structural coordinates and Rosetta-dockings of KCNE1
to Kv7.1 that suggest binding of KCNE1 to the so-called “gain-of-
function cleft”, a space formed between two adjacent voltage sensor
domains and the outer PD (Smith et al., 2007; Kang et al., 2008).
Localized to the center of the α-helical KCNE1 transmembrane
segment are the residues G52FFGFFTLG60. As predicted, this α-
helical transmembrane domain allows for flexibility at glycine
residues G52, G55, and G60 (Tian et al., 2007; Kang et al., 2008;
Strutz-Seebohm et al., 2011). Key to functional modulation of
Kv7.1 by KCNE1 is the residue T58 (Melman et al., 2002). The sur-
rounding phenylalanine residues generate a bulky aromatic cuff.
The combination of these structural elements may enable forma-
tion of a stable hydrogen bond with residue S338 in Kv7.1 and
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diverse van der Waals interactions with residues in S4 and the
S4–S5 linker region as well as S5/S6 amino acids F270, F339, and
F340 to stabilize a pre-open closed state. The combination of the
Kv7.1/KCNE1 models, the closed state, the pre-open closed state
and the open state model are in good agreement with published
results of several experimental studies (Smith et al., 2007; Kang
et al., 2008; Strutz-Seebohm et al., 2011). The modeled trans-
membrane domain structures can be used to assess a molecular
view on the slow activation of I Ks (Figure 5). The three states
closed, pre-open, and open can be used for morphing calculations
(Echols et al., 2003). The basic idea is that the channel under-
goes conformational transitions from closed (C) to pre-open (C∗),
from pre-open (C∗) to open (O), and from open (O) to closed
(C) states. These seem to represent the major steps in the Kv7.1
and Kv7.1/KCNE1 gating (Silva et al., 2009). The position of the
voltage sensor is “down” for the closed state and “up” for the
pre-open and open states (Tian et al., 2007; Kang et al., 2008;
Silva et al., 2009; Strutz-Seebohm et al., 2011). The interaction of
KCNE1T58 with Kv7.1S338 and Kv7.1F339 may uncouple the gate
at the lower S6 from the S4–S5 linker, which leads to S6 bundle
crossing and closure of the gate (Strutz-Seebohm et al., 2011).
The formation of the S6 bundle upon S4–S5 linker uncoupling
may be supported by the lack of a central S6 gating hinge (See-
bohm et al., 2006). The uncoupling of S4–S5 by KCNE1 during
closed state inactivation shows similarities to an uncoupling event
of the PD from the voltage sensor domain during closed state
inactivation of some Kv channels as described by the group of
Bähring et al. (2012). In the light of the ongoing discussion about
fixed stoichiometry of two KCNE1 subunits per Kv7.1 tetramer
vs. variable stoichiometry it is fair to study a channel complex
with two KCNE1 subunits docked to four Kv7.1 subunits (Strutz-
Seebohm et al., 2011). This stoichiometry is consistent with
both hypotheses. Morphing experiments have been performed
(Figure 5). As expected the gating is associated with large struc-
tural rearrangements in the voltage sensor domain. On the other
hand the PD is rather rigid in the region around the selectivity
filter. The KCNE1 transmembrane segment undergoes relatively
small rearrangements during the gating steps C C∗ and O C
but dramatic structural alterations during the C∗ O transi-
tion (Figure 5; the extent of structural rearrangement around
key residue KCNE1 T58 is indicated by a yellow arrow). This
dramatic rearrangement of KCNE1 associated with the C∗ O
transition may generate an energetic barrier that can only slowly
be overcome, resulting in dramatically slowed activation, the piv-
otal characteristic of Kv7.1/KCNE1 gating. Clearly, these models
present a preliminary view on the dynamics of Kv7.1/KCNE1 chan-
nels. Silva et al. (2009) modeled further structural closed states
of the Kv7.1 voltage sensor module. Incorporation of these data
in future Kv7.1/KCNE1 morphing experiments may prove valu-
able. Increase in knowledge combined with the already available
data, upcoming improvements in computational methodology,
and decreasing computational costs will allow for much more facil-
itated dynamic modeling of Kv7.1/KCNE1 channel gating in the
future.
The novel structural “snapshots” allow for a better under-
standing of Kv7.1/KCNE1 molecular pharmacology. Several
FIGURE 5 | Dynamic model of gating transitions in Kv7.1/KCNE1
channels. The closed (C), pre-open (C*), and open (O) state models
described by Smith et al. (2007) and Strutz-Seebohm et al. (2011) were
used to generate dynamic models using simple morphing approaches. The
gating of Kv7.1/KCNE1 channels can be approximated by a simplified
circular gating model. Major gating steps are C⇒C* (A), C*⇒O (B), and
O⇒C (C) (colors as indicated in the letters above the models). For clarity
the central axes of the KCNE1 start and end models are marked by the
yellow dashed lines, and the direction and extent of the proposed motion is
indicated by the yellow arrow. In (A) the KCNE1 start model is shown in red
and the end model in magenta. The morphs indicate larger motions of
KCNE1 during channel gating in the gating cleft of Kv7.1 channels. A
particularly large gating motion around Thr58 is seen from C*⇒O (B),
suggesting a major energetic barrier. This may be the molecular basis of the
dramatically slowed activation of Kv7.1 by association with KCNE1.
However, calculation of energies on the models is highly speculative
because specific interactions with surrounding membrane molecules [e.g.,
PI(4,5)P2] would be highly influential, and the current knowledge on
lipid-channel interactions is not sufficient to allow for precise calculations.
Kv7.1/KCNE1 inhibitors and activators bind to distinct sites in
state-dependent manner (Lerche et al., 2000, 2007; Seebohm et al.,
2001b, 2003a; Chen et al., 2003b). Docking of various compounds
to the different models and experimental verifications are now
possible. An interesting observation is that the KCNE1 transmem-
brane segment induces large fenestrations in the Kv7.1 channel
pre-open state that may allow for a novel access pathway not
present in Kv7.1 homomeric channels (Strutz-Seebohm et al.,
2011). Affected by these structural effects is the central cavity,
the binding and blocking site of several Kv7.1/KCNE1 inhibitors
(Lerche et al., 2000, 2007; Seebohm et al., 2003a). This altered
structure could be used as a scaffold for the computer-aided
design of specific Kv7.1/KCNE1 modulators not targeting homo-
meric Kv7.1 channels, which would be a prerequisite for tissue
specific pharmacology (Seebohm et al., 2003b; Strutz-Seebohm
et al., 2011). Insights into KCNE1-specific molecular pharma-
cology will be highly valuable for both drug development and
safety pharmacology alike (Towart et al., 2009; Pugsley et al.,
2011).
Upcoming physiological, pathophysiological, pharmacological,
and structural analyses will fill the gaps in our current knowl-
edge, and therefore the old Kv7.1/KCNE1 channel faces an exciting
future. Let’s dance the KCNQ1 tango!
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APPENDIX
Table A1 | Kv7.1 expression in mammalian tissues.
Specified tissue Species mRNA/protein Reference
Brain Mouse mRNA Lee et al. (2000)
Mouse mRNA Ohya et al. (2003)
Mouse mRNA Yeung et al. (2007)
Mouse mRNA Iannotti et al. (2010)
Inner ear Mouse mRNA Neyroud et al. (1997)
Mouse mRNA/protein Nicolas et al. (2001)
Mouse Protein Knipper et al. (2006)
Rat mRNA Liang et al. (2006)
Rat Protein Hur et al. (2007)
Guinea pig mRNA Liang et al. (2006)
Trachea Mouse mRNA/protein Grahammer et al. (2001b)
Thyroid gland Mouse mRNA/protein Frohlich et al. (2011)
Human mRNA Yang et al. (1997)
Human mRNA Frohlich et al. (2011)
Thymus Mouse mRNA Demolombe et al. (2001)
Human mRNA Chouabe et al. (1997)
Lung Mouse mRNA Demolombe et al. (2001)
Human mRNA Wang et al. (1996b)
Human mRNA Sanguinetti et al. (1996)
Human mRNA Chouabe et al. (1997)
Human mRNA Yang et al. (1997)
Heart Mouse mRNA Barhanin et al. (1996)
Mouse mRNA Lee et al. (2000)
Mouse mRNA Casimiro et al. (2001)
Mouse mRNA Demolombe et al. (2001)
Mouse mRNA Ohya et al. (2003)
Mouse mRNA Yeung et al. (2007)
Mouse mRNA Iannotti et al. (2010)
Mouse mRNA Strutz-Seebohm et al. (2006)
Mouse Protein Knollmann et al. (2007)
Rat Protein Rasmussen et al. (2004)
Guinea pig mRNA/protein Zicha et al. (2003)
Guinea pig Protein Nicolas et al. (2008)
Ferret mRNA Brahmajothi et al. (1997)
Rabbit mRNA/protein Zicha et al. (2003)
Horse Protein Finley et al. (2002)
Canine mRNA/protein Han et al. (2002)
Human mRNA Wang et al. (1996b)
Human mRNA Sanguinetti et al. (1996)
Human mRNA Chouabe et al. (1997)
Human mRNA Yang et al. (1997)
Human mRNA Bendahhou et al. (2005)
Human mRNA Gaborit et al. (2007)
Human mRNA Frohlich et al. (2011)
Human mRNA/protein Zicha et al. (2003)
Liver Mouse mRNA Lee et al. (2000)
Mouse mRNA Demolombe et al. (2001)
Spleen Mouse mRNA Demolombe et al. (2001)
Human mRNA Chouabe et al. (1997)
(Continued)
www.frontiersin.org August 2012 | Volume 3 | Article 142 | 13
Wrobel et al. Kv7.1/KCNE1 interaction
Table A1 | Continued
Specified tissue Species mRNA/protein Reference
Pancreas Mouse mRNA Demolombe et al. (2001)
Rat Protein Lee et al. (2008)
Human mRNA Sanguinetti et al. (1996)
Human mRNA Chouabe et al. (1997)
Human mRNA Yang et al. (1997)
Stomach Mouse mRNA Lee et al. (2000)
Mouse mRNA Demolombe et al. (2001)
Mouse mRNA/protein Dedek and Waldegger (2001)
Mouse Protein Grahammer et al. (2001a)
Mouse Protein Heitzmann et al. (2004)
Mouse Protein Heitzmann and Warth (2007)
Rat mRNA/protein Lambrecht et al. (2005)
Human mRNA Yang et al. (1997)
Human mRNA Frohlich et al. (2011)
Human Protein Grahammer et al. (2001a)
Colon Mouse mRNA/protein Dedek and Waldegger (2001)
Rat mRNA Kunzelmann et al. (2001)
Human mRNA Chouabe et al. (1997)
Human mRNA Yang et al. (1997)
Human mRNA Frohlich et al. (2011)
Human mRNA/protein Horikawa et al. (2005)
Small intestine Mouse mRNA Demolombe et al. (2001)
Mouse mRNA/protein Dedek and Waldegger (2001)
Human mRNA Chouabe et al. (1997)
Human mRNA Yang et al. (1997)
Kidney Mouse mRNA Barhanin et al. (1996)
Mouse mRNA Lee et al. (2000)
Mouse mRNA Demolombe et al. (2001)
Mouse Protein Vallon et al. (2001)
Human mRNA Wang et al. (1996b)
Human mRNA Sanguinetti et al. (1996)
Human mRNA Chouabe et al. (1997)
Human mRNA Yang et al. (1997)
Uterus Mouse mRNA/protein McCallum et al. (2009)
Placenta Human mRNA Wang et al. (1996b)
Human mRNA Sanguinetti et al. (1996)
Human mRNA Chouabe et al. (1997)
Human mRNA Yang et al. (1997)
Ovary Human mRNA Chouabe et al. (1997)
Prostate Human mRNA Chouabe et al. (1997)
Human mRNA Yang et al. (1997)
Testis Human mRNA Chouabe et al. (1997)
Blood vessels Mouse mRNA/protein Ohya et al. (2003)
Mouse mRNA/protein Yeung et al. (2007)
Rat mRNA Brueggemann et al. (2007)
Rat mRNA Mackie et al. (2008)
Rat mRNA Joshi et al. (2009)
Rat mRNA/protein Zhong et al. (2010)
Human mRNA/protein Ng et al. (2011)
Skeletal muscle Mouse mRNA Demolombe et al. (2001)
Mouse mRNA Iannotti et al. (2010)
Rat mRNA Roura-Ferrer et al. (2008)
Peripheral blood leukocytes Human mRNA Chouabe et al. (1997)
Hematopoietic stem cells Human mRNA Park et al. (2011)
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